<DOC>
	<DOCNO>NCT00000131</DOCNO>
	<brief_summary>To determine whether photocoagulation therapy help prevent iris neovascularization eye central vein occlusion ( CVO ) evidence ischemic retina . To assess whether grid-pattern photocoagulation therapy reduce loss central visual acuity due macular edema secondary CVO . To develop new data describe course prognosis eye CVO .</brief_summary>
	<brief_title>Central Vein Occlusion Study ( CVOS )</brief_title>
	<detailed_description>Central vein occlusion common retinal vascular disorder potentially blinding complication . The two major complication reduce central vision cause macular edema neovascular glaucoma cause iris neovascularization . Other clinical trial show laser photocoagulation effective treatment complication find diabetic retinopathy branch vein occlusion , feature common CVO : neovascularization reduce visual acuity cause macular edema occur three disorder . Evidence small-scale study suggest grid pattern photocoagulation reduces macular edema CVO patient , although associate change visual acuity variable . The CVOS detail investigation grid pattern photocoagulation large randomize group patient . Eligible patient divide four group : Group N : Eyes extensive retinal ischemia ( least 10 disc area nonperfusion ) randomly assign receive panretinal photocoagulation nontreatment unless iris neovascularization develop . Group M : Eyes visual loss ascribable macular edema randomly assign receive grid-pattern photocoagulation nontreatment . Group P : Eyes relatively perfuse retina follow provide information natural history disease . Group I : Indeterminate eye retina could visualize accurately hemorrhage follow natural history study . Green argon laser slit lamp delivery system use treatment . Photographic documentation retinal change obtain entry , post-treatment , specified followup visit period least 3 year . The frequency followup visit vary accord group CVO patient assign . Visual acuity , primary outcome factor group macular edema , measure accord modify Early Treatment Diabetic Retinopathy Study protocol visit .</detailed_description>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<criteria>Men woman must age 21 old willing return followup visit 3 year follow assignment appropriate group randomization . Each four group specific eligibility criterion . Patients retinal vascular disease specify criterion , diabetic retinopathy , ineligible . Patients macular disease due CVO ineligible portion study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Central Vein Occlusion</keyword>
	<keyword>Ischemic Retina</keyword>
</DOC>